MedCana Subsidiary in Colombia Enters Negotiations with Australian Firm for Pharma Cannabis Supply
Rhea-AI Summary
MedCana (OTC: SFWJ), a global infrastructure holding company in the pharmaceutical-grade cannabis industry, has announced that one of its Colombian subsidiaries is in negotiations with an Australian pharmaceutical firm for a medical-grade cannabis supply agreement. The deal is expected to generate $100,000 to $200,000 in monthly revenue, potentially reaching $1.2 to $2.4 million annually.
CEO Jose Gabriel Diaz described this as a pivotal moment for MedCana's global expansion to meet the growing demand for pharmaceutical-grade cannabis. MedCana, formerly known as Software Effective Solutions, is focused on developing companies in the agricultural technology and cannabis industries.
Positive
- Potential annual revenue of $1.2 to $2.4 million from the new supply agreement
- Expansion into the Australian pharmaceutical cannabis market
- Demonstrates MedCana's ability to secure international contracts
Negative
- Agreement still in negotiation phase, not finalized
- Exact revenue figures are projections, not guaranteed
News Market Reaction 1 Alert
On the day this news was published, SFWJ declined 8.33%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MedCana to enter into supply Agreement worth
The agreement is projected to provide between
Jose Gabriel Diaz, CEO of MedCana, stated, "This agreement represents a pivotal moment for MedCana as we continue expanding globally to meet the increasing demand for pharmaceutical-grade cannabis."
About SFWJ/Medcana
Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings.
For more information, please visit: www.MedCana.net
Or connect with us via:
MedCana | LinkedIn
https://X.com/@MedcanaCo
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
View original content:https://www.prnewswire.com/news-releases/medcana-subsidiary-in-colombia-enters-negotiations-with-australian-firm-for-pharma-cannabis-supply-302277352.html
SOURCE MedCana
FAQ
What is the potential annual revenue for MedCana (SFWJ) from the new Australian supply agreement?
Which subsidiary of MedCana (SFWJ) is negotiating the cannabis supply agreement?
What type of cannabis product will MedCana (SFWJ) supply to the Australian firm?
When did MedCana (SFWJ) announce the negotiations for the Australian supply agreement?
